Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile. (16th March 2023)
- Record Type:
- Journal Article
- Title:
- Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile. (16th March 2023)
- Main Title:
- Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile
- Authors:
- Palacios, Alfredo
Rodriguez Cairoli, Federico
Balan, Dario
Balmaceda, Carlos
Augustovski, Federico
Pichon-Riviere, Andres
Bardach, Ariel - Abstract:
- ABSTRACT: Objective: To estimate the budget impact of covering the FreeStyle Libre Flash Continuous Glucose Monitoring System (FSL) for type 1 Diabetes Mellitus patients (T1DM), compared to self-monitoring of blood glucose (SMBG), from the perspective of public and private third-party payers in Chile. Methods: A budget impact model was developed to estimate the cost difference between SMBG and FSL over five years. Two FSL coverage schemes were assessed. Input parameters were retrieved from the literature review and complemented by expert opinion. Healthcare costs were estimated by a micro-costing approach and reported in USD. Results: For a public sector third-party payer, incorporating FSL implied a cost increase up to USD 0.013 per member per month (PMPM) for the fifth year under the broad coverage scheme and a net saving of 0.0001 PMPM (all years) under the restricted coverage scheme. From a private sector third-party payer, incorporating FSL implied savings up to USD 0.028 PMPM (fifth year) for the broad coverage scheme and up to USD 0.012 PMPM (fifth year) for the restricted scheme. Conclusion: Incorporating the FSL for T1DM patients was associated with a marginal incremental cost for the public sector third-party payer and cost savings in Chile's private healthcare sector.
- Is Part Of:
- Expert review of pharmacoeconomics & outcomes research. Volume 23:Number 3(2023)
- Journal:
- Expert review of pharmacoeconomics & outcomes research
- Issue:
- Volume 23:Number 3(2023)
- Issue Display:
- Volume 23, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 23
- Issue:
- 3
- Issue Sort Value:
- 2023-0023-0003-0000
- Page Start:
- 353
- Page End:
- 363
- Publication Date:
- 2023-03-16
- Subjects:
- Budget impact analysis -- Chile -- cost analysis -- diabetes mellitus -- flash glucose monitoring -- self-monitoring of blood glucose -- severe hypoglycemic events
Pharmacology -- Economic aspects -- Periodicals
338.47615105 - Journal URLs:
- http://www.future-drugs.com/loi/erp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737167.2023.2171989 ↗
- Languages:
- English
- ISSNs:
- 1473-7167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002996
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 25986.xml